Texas

Resilience System


You are here

Guinea

TB, Malaria and H.I.V. are spreading amid the coronavirus pandemic

It begins with a mild fever and malaise, followed by a painful cough and shortness of breath. The infection prospers in crowds, spreading to people in close reach. Containing an outbreak requires contact tracing, as well as isolation and treatment of the sick for weeks or months.

This insidious disease has touched every part of the globe. It is tuberculosis, the biggest infectious-disease killer worldwide, claiming 1.5 million lives each year.

Problem, Solution, SitRep, or ?: 

Remittances: They Crossed Oceans to Lift Their Families Out of Poverty. Now, They Need Help.

...Around the globe, the pandemic has jeopardized a vital artery of finance supporting hundreds of millions of families — so-called remittances sent home from wealthy countries by migrant workers. As the coronavirus has sent economies into lockdown, sowing joblessness, people accustomed to taking care of relatives at home have lost their paychecks, forcing some to depend on those who have depended on them.

Problem, Solution, SitRep, or ?: 

WHO’s list of guidance on COVID-19

There’s a lot of information out there about how governments, health professionals and the general public should respond to the COVID-19 pandemic. WHO has published guidance and advice every step of the way. 

During health emergencies like the COVID-19 pandemic, one of WHO’s most vital roles is to gather data and research from around the world, evaluate it, and then advise countries on how to respond.

Problem, Solution, SitRep, or ?: 

Tekmira Ebola drug succeeds in small monkey study

REUTERS by Aharon Begley                                                                    Aug. 22, 2015
NEW YORK --An experimental Ebola drug from Tekmira Pharmaceuticals Corp cured all three monkeys intentionally infected with the virus, scientists reported on Wednesday, the first such success against the strain of Ebola in West Africa's 2014-2015 outbreak.

Although other experimental treatments appeared to help Ebola patients last year, especially in the United States, those one-time uses cannot prove efficacy against the "Makona" strain, since patients' recovery might be due to other causes. Similarly, drugs, including Mapp Biopharmaceutical's ZMapp, cured monkeys in lab experiments, but in a strain of Ebola different from that responsible for the current outbreak, the worst ever recorded.

"We can't say for certain that an experimental drug that works against one strain will work in another, even if they're almost identical genetically," said Thomas Geisbert of the University of Texas Medical Branch, senior author of the study published in the journal Nature.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

2 new ebola vaccines pass important early test, researchers say

NEW YORK TIMES   by Denis Grady                                                                 April 9. 2015

Two  new Ebola vaccines have passed an important test, protecting monkeys against the strain of the virus responsible for the current deadly outbreak, researchers reported on Wednesday. Only one dose was needed, and there were no apparent side effects..

Thomas W. Geisbert, an Ebola expert at the University of Texas Medical Branch in Galveston, in his office. Credit Michael Stravato for The New York Times

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Exclusive: take a first look at the next generation ebola-protection suit

QUARTZ  by Grace Dobush                                         March 13, 2015

AUSTIN, Texas—Perhaps the most surprising and important product debuting at SXSW Interactive this year is a personal protective equipment (PPE) prototype for health care workers dealing with Ebola, a tangible result of the U.S. government adapting the culture of innovation and design thinking so key in the startup world.

A team from the U.S. Agency for International Development demonstrated the traditional Ebola suit and the new suit in a preview for Quartz....

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Guinea
howdy folks
Page loaded in 0.711 seconds.